DK0937153T3 - Humane monoklonale antistoffer, der er specifikke for hepatitis C-virus (HCV) E2 antigen - Google Patents
Humane monoklonale antistoffer, der er specifikke for hepatitis C-virus (HCV) E2 antigenInfo
- Publication number
- DK0937153T3 DK0937153T3 DK97920721T DK97920721T DK0937153T3 DK 0937153 T3 DK0937153 T3 DK 0937153T3 DK 97920721 T DK97920721 T DK 97920721T DK 97920721 T DK97920721 T DK 97920721T DK 0937153 T3 DK0937153 T3 DK 0937153T3
- Authority
- DK
- Denmark
- Prior art keywords
- hcv
- antigen
- monoclonal antibodies
- hepatitis
- virus
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title abstract 7
- 102000008482 12E7 Antigen Human genes 0.000 title abstract 3
- 108010020567 12E7 Antigen Proteins 0.000 title abstract 3
- 230000027455 binding Effects 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 238000001261 affinity purification Methods 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000000159 protein binding assay Methods 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/635,109 US6538114B1 (en) | 1996-04-19 | 1996-04-19 | Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
US08/844,215 US6747136B2 (en) | 1996-04-19 | 1997-04-17 | Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
PCT/EP1997/001977 WO1997040176A1 (en) | 1996-04-19 | 1997-04-18 | Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0937153T3 true DK0937153T3 (da) | 2009-05-04 |
Family
ID=27092301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97920721T DK0937153T3 (da) | 1996-04-19 | 1997-04-18 | Humane monoklonale antistoffer, der er specifikke for hepatitis C-virus (HCV) E2 antigen |
Country Status (8)
Country | Link |
---|---|
US (1) | US6747136B2 (da) |
EP (1) | EP0937153B1 (da) |
AT (1) | ATE419361T1 (da) |
CA (1) | CA2262423C (da) |
DE (1) | DE69739187D1 (da) |
DK (1) | DK0937153T3 (da) |
ES (1) | ES2320051T3 (da) |
WO (1) | WO1997040176A1 (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6951646B1 (en) | 1998-07-21 | 2005-10-04 | Genmab A/S | Anti hepatitis C virus antibody and uses thereof |
US7091324B2 (en) * | 1998-11-05 | 2006-08-15 | Board Of Trustees Of Leland Stanford Junior University | Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
EP1127170A4 (en) * | 1998-11-05 | 2005-04-27 | Univ Leland Stanford Junior | HUMAN MONOCLONAL ANTIBODIES TO HUMAN PAN-HEPATITIS C VIRUS |
DE19919585A1 (de) | 1999-04-29 | 2000-12-07 | Cmi Ag | Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen |
JP5498637B2 (ja) * | 1999-07-28 | 2014-05-21 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | C型肝炎ウイルス抗原免疫アッセイ検出システム |
US6815160B1 (en) | 1999-07-28 | 2004-11-09 | Chiron Corporation | Hepatitis C viral antigen immunoassay detection systems |
IL137522A (en) * | 2000-07-26 | 2007-06-17 | Drk Blutspendediendst Baden Wu | HCV human monoclonal antibody E2 glycoprotein antibody |
EP1355947A2 (en) | 2000-12-01 | 2003-10-29 | The Government of the United States of America, as Represented by the Secretary, Department of Health and Human Services | Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
DK2316940T3 (da) | 2000-12-18 | 2013-11-04 | Dyax Corp | Fokuserede biblioteker af genpakker |
ATE425187T1 (de) | 2001-01-12 | 2009-03-15 | Molecules Of Man Ab | Materialien und methoden zur behandlung von hepatitis c |
WO2002059340A1 (en) * | 2001-01-26 | 2002-08-01 | The Scripps Research Institute | Immunopolypeptides to hepatitis c virus |
US20070178065A1 (en) * | 2002-05-03 | 2007-08-02 | Lattime Edmund C | Neutralizing factors as vaccine adjuvants |
AU2003272491B2 (en) * | 2002-09-18 | 2008-10-02 | The Trustees Of The University Of Pennsylvania | Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
JP5642972B2 (ja) | 2007-02-21 | 2014-12-17 | ユニバーシティー オブ マサチューセッツUniversity of Massachusetts | C型肝炎ウイルス(hcv)に対するヒト抗体およびその使用 |
US20100104555A1 (en) * | 2008-10-24 | 2010-04-29 | The Scripps Research Institute | HCV neutralizing epitopes |
BR112012029881A2 (pt) | 2010-05-25 | 2019-09-24 | Inserm (Institut National De La Santé De La Recherche Médicale) | combinação de anticorpos anti-envelope e anticorpos anti-receptor para o tratamento e a presenção de infecção por hcv |
CN115028712B (zh) * | 2021-05-08 | 2024-02-09 | 南昌大学 | 一种高亲和力抗丙型肝炎病毒的全人源单克隆抗体及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5308750A (en) | 1989-12-22 | 1994-05-03 | Abbott Laboratories | Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same |
EP0447984A1 (en) | 1990-03-20 | 1991-09-25 | Abbott Laboratories | Hyperimmune globulin against hepatitis C virus and method for making same |
CA2109602C (en) | 1990-07-10 | 2002-10-01 | Gregory P. Winter | Methods for producing members of specific binding pairs |
FR2677372B1 (fr) * | 1991-06-06 | 1994-11-10 | Pasteur Institut | Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques. |
WO1993006213A1 (en) | 1991-09-23 | 1993-04-01 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
-
1997
- 1997-04-17 US US08/844,215 patent/US6747136B2/en not_active Expired - Fee Related
- 1997-04-18 WO PCT/EP1997/001977 patent/WO1997040176A1/en active Application Filing
- 1997-04-18 DE DE69739187T patent/DE69739187D1/de not_active Expired - Lifetime
- 1997-04-18 DK DK97920721T patent/DK0937153T3/da active
- 1997-04-18 AT AT97920721T patent/ATE419361T1/de not_active IP Right Cessation
- 1997-04-18 EP EP97920721A patent/EP0937153B1/en not_active Expired - Lifetime
- 1997-04-18 CA CA2262423A patent/CA2262423C/en not_active Expired - Lifetime
- 1997-04-18 ES ES97920721T patent/ES2320051T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0937153A1 (en) | 1999-08-25 |
US20020016445A1 (en) | 2002-02-07 |
WO1997040176A1 (en) | 1997-10-30 |
ATE419361T1 (de) | 2009-01-15 |
US6747136B2 (en) | 2004-06-08 |
EP0937153B1 (en) | 2008-12-31 |
CA2262423A1 (en) | 1997-10-30 |
DE69739187D1 (de) | 2009-02-12 |
CA2262423C (en) | 2010-08-03 |
ES2320051T3 (es) | 2009-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0937153T3 (da) | Humane monoklonale antistoffer, der er specifikke for hepatitis C-virus (HCV) E2 antigen | |
Tissot et al. | Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide | |
ATE425989T1 (de) | Proteinreinigungsverfahren | |
DK0770679T4 (da) | HCV-specifikke peptider, sammensætninger dertil og anvendelse deraf | |
DK1129190T3 (da) | Human TSLP DNA og polypeptider | |
HUP9802401A2 (hu) | Az emberi gp39-protein különböző epitópjaira specifikus monoklonális antitestek, valamint eljárások az ilyen antitestek diagnosztikai és terápiás alkalmazására | |
ES2139607T3 (es) | Anticuerpos monoclonales contra las proteinas e2/ns1 supuestas vhc y procedimientos de utilizacion de estos anticuerpos. | |
IL212686A (en) | Human IgM antibodies that bind to oligodendrocytes and their preparations and their uses | |
FI942369A0 (fi) | Hepatitis-C-virustesti | |
EA199800046A1 (ru) | Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента | |
DK0853633T3 (da) | Humant monoklonalt antistof imod hepatitis B virus overfladeantigen (HBVsAg) | |
DK0500659T3 (da) | Monoklonale antistoffer. | |
EA201001190A1 (ru) | Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков | |
ATE382696T1 (de) | Immunoreaktive antigene des hepatitis e viruses | |
DK1181366T4 (da) | Mammale receptorproteiner, beslægtede reagenser og fremgangsmåder | |
DE59508137D1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
DE69736158D1 (de) | Glutamine: Fructose-6-Phosphat Amidotransferase (GFAT), ihre Herstellung und Verwendung | |
Dehghanpisheh et al. | Retrovirally induced mouse anti‐TCR monoclonals can synergize the in vitro proliferative T cell response to bacterial superantigens | |
Michaelsen | Evidence of 15 S–S Bridges in the Hinge Region of Human 530 | |
ATE174060T1 (de) | Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden | |
DK0852586T3 (da) | Anvendelse af et 24 kDa-protein til behandling og diagnosticering af en HCV-infektion | |
BR0204599A (pt) | Sequências de proteìna de núcleo de hcv | |
Wasniowska et al. | An immunoblotting procedure for screening glycophorins and band 3 protein in the same blots: Identification of glycophorin and band 3 variant forms | |
UA36086A (uk) | Тест-система для підтвердження наявності антитіл проти вірусу гепатиту с (іфа-п-hcv) |